Register for our free email digests:
Biosense Webster Inc.
Division of Johnson & Johnson
www.biosensewebster.com
Latest From Biosense Webster Inc.
J&J’s Investment In Medical Device Businesses Is Starting To Pay Off
Johnson & Johnson's medical device businesses grew 5.3% on an organic basis in the third quarter, led by the Biosense Webster electrophysiology business. The company is increasing R&D investment, especially in robotic surgery, to boost its surgery and orthopedics businesses.
Johnson & Johnson Growth Led By Biosense Webster And Cerenovus
Johnson & Johnson’s leadership remains optimistic about the future of its medical device divisions despite reporting a 2.6% revenue decline in the first six months of 2019 compared to the same period of 2018.
Long-Term Analysis Shows Boston Scientific’s Watchman Device Saves Money
An analysis of pooled five-year data from the PROTECT AF and PREVAIL trials, show left-atrial appendage closure to prevent stroke in patients with atrial fibrillation is not only cost‐effective compared to treatment with warfarin and other anticoagulant drugs, but saves money over time.
Starts & Stops: J&J Launches IDE Trial Of 90-Watt RF Ablation Catheter; Vectorious Starts Trial Of V-LAP HF Monitor
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by MedDeviceTracker. This edition covers trial announcements from Feb. 4 through Feb. 10, including from Johnson & Johnson, Relievant Medsystems, Vectorious, Leviticus, and Kaia Health.
Company Information
- Industry
-
Medical Devices
- Diagnostic Imaging Equipment & Supplies
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Cardiovascular
- Alias(es)
- Biosense Inc.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Johnson & Johnson
- Senior Management
- Roy Tanaka, Pres.
- Contact Info
-
Biosense Webster Inc.
Phone: (909) 839-8500
3333 Diamond Canyon Rd.
Diamond Bar, CA 91765
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice